Eyebright Historical Balance Sheet
688050 Stock | 89.09 0.66 0.74% |
Trend analysis of Eyebright Medical Technology balance sheet accounts such as Short Long Term Debt Total of 196.6 M, Other Current Liabilities of 130.4 K or Total Current Liabilities of 396.7 M provides information on Eyebright Medical's total assets, liabilities, and equity, which is the actual value of Eyebright Medical to its prevalent stockholders. By breaking down trends over time using Eyebright Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Eyebright Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Eyebright Medical is a good buy for the upcoming year.
Eyebright Medical Inventory |
|
Eyebright |
About Eyebright Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Eyebright Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Eyebright Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Eyebright currently owns. An asset can also be divided into two categories, current and non-current.
Eyebright Medical Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Eyebright Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Eyebright Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Eyebright Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Eyebright Medical Technology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most accounts from Eyebright Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Eyebright Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Eyebright Medical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 196.6 M, whereas Other Current Liabilities is forecasted to decline to about 130.4 K.
2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 162.8M | 187.2M | 196.6M | Total Assets | 2.2B | 3.1B | 3.2B |
Eyebright Medical balance sheet Correlations
Click cells to compare fundamentals
Eyebright Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Eyebright Medical balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 685.8M | 1.6B | 2.0B | 2.2B | 3.1B | 3.2B | |
Short Long Term Debt Total | 7.7M | 894.5K | 154.8M | 162.8M | 187.2M | 196.6M | |
Other Current Liab | 21.9M | 74.9M | 133.9M | 133.9M | 137.3K | 130.4K | |
Total Current Liabilities | 23.1M | 77.1M | 139.4M | 147.7M | 377.8M | 396.7M | |
Total Stockholder Equity | 617.6M | 1.5B | 1.7B | 1.9B | 2.1B | 1.2B | |
Property Plant And Equipment Net | 183.1M | 267.1M | 558.7M | 674.2M | 1.3B | 1.3B | |
Net Debt | (195.4M) | (536.8M) | (318.0M) | (192.1M) | (172.9M) | (181.5M) | |
Retained Earnings | 2.5M | 90.0M | 213.5M | 391.4M | 647.2M | 679.5M | |
Accounts Payable | 280.9K | 2.2M | 5.6M | 13.9M | 49.0M | 51.5M | |
Cash | 196.3M | 536.8M | 472.9M | 354.9M | 536.7M | 308.0M | |
Non Current Assets Total | 351.3M | 492.4M | 928.9M | 1.2B | 2.0B | 2.1B | |
Non Currrent Assets Other | 42.2M | 87.2M | 86.2M | 317.6M | 170.0M | 107.0M | |
Cash And Short Term Investments | 196.3M | 537.1M | 473.4M | 836.9M | 962.4M | 1.0B | |
Common Stock Shares Outstanding | 78.5M | 89.4M | 105.1M | 105.3M | 189.5M | 106.7M | |
Liabilities And Stockholders Equity | 685.8M | 1.6B | 2.0B | 2.2B | 2.6B | 2.7B | |
Non Current Liabilities Total | 15.1M | 13.8M | 168.0M | 176.6M | 328.1M | 344.5M | |
Inventory | 60.8M | 59.1M | 56.0M | 78.8M | 181.4M | 190.4M | |
Other Current Assets | 12.9M | 466.6M | 504.1M | 11.3M | 36.5M | 34.6M | |
Other Stockholder Equity | 536.2M | 1.3B | 1.4B | 1.4B | 1.6B | 845.9M | |
Total Liab | 38.3M | 90.9M | 307.5M | 324.3M | 705.9M | 741.1M | |
Total Current Assets | 334.5M | 1.1B | 1.1B | 1.1B | 1.0B | 718.5M | |
Intangible Assets | 100.6M | 112.9M | 127.8M | 140.3M | 252.2M | 264.8M | |
Common Stock | 78.8M | 78.8M | 105.1M | 105.2M | 121.0M | 93.5M |
Currently Active Assets on Macroaxis
Other Information on Investing in Eyebright Stock
Balance Sheet is a snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Eyebright Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Eyebright Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Eyebright currently owns. An asset can also be divided into two categories, current and non-current.